Dear Customer:

We are pleased to inform you that Florida Pharmaceutical Products, LLC “FPP”, has completed the acquisition of certain assets of Quinn Pharmaceuticals, LLC, “Quinn”. The JV between FPP and Quinn for Sales, Marketing, and Distribution of the Quinn label in 2019 will now transition over to FPP’s full ownership and all agreements will be assigned to FPP.

All members of the FPP team remain in place and continue to service your account. The operation of the Quinn Label will be maintained under FPP’s ownership. We will continue to provide you with service and support for all of Quinn’s current products, while we prepare to launch the first FPP-labeled products in Q3 2020. There will be no disruption in service of the Quinn product portfolio.

Please note the remittance address below.
All payments should be sent to the FPP offices:

Quinn Pharmaceuticals, c/o FPP
6111 Broken Sound Parkway NW
Suite 160
Boca Raton, FL 33487

FPP continues to add to its pipeline of ANDA’s in both development and licensing. This will assure a steady stream of new generic products in 2020 and beyond.

We are excited to take this next step that the Asset Purchase has created for FPP and Quinn, and also for our Customers. We look forward to continuing to serve your needs.

Sincerely,